Covaxin : India’s First Vaccine Against Coronavirus Moves Ahead For Human Trials

Must read

Major Data Privacy Breach By Delhi University on Admit Card Webpage

On Thursday, two users, Vivek Prasad and Ribhav, reported the serious data privacy breach problems while downloading the DU admit card 2020 from the...

DU Exams 2020 : Final Year Exams Postponed; Will Now Commence From July 10

University of Delhi: The open book examinations (OBE) for the final year students of the graduation and post-graduation courses have been postponed in view...

The Custodial Death of Jayaraj & Fenix : What Happened With Them Is Nothing But Barbaric

According to the Oxford dictionary, the term torture means “The action or practise of inflicting severe pain or suffering on someone as a punishment...

Hyderabad-based biotechnology firm, Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), has developed India’s first COVID-19 vaccine and has gotten a nod from the Drug Controller General of India (DCGI) to conduct Phase I and II human trials. The permission for human clinical trials was granted by DCGI after Bharat Biotech submitted results generated from preclinical studies, demonstrating safety and immune response.

COVAXIN is an indigenously developed inactivated vaccine. An inactivated vaccine is prepared by growing the virus on a large scale and injecting an inactive form of it inside a human body to gain immunity.

- Advertisement -

The human clinical trials are scheduled to commence in July across the country, and the results will be out by October. However, details about when will it be launched and at what price, have not been disclosed. “The SARS-CoV-2 strain was isolated in NIV, Pune, and transferred to Bharat Biotech. The indigenous inactivated vaccine was developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad, India”, the company said.

Bharat Biotech has been in the vanguard of creating breakthrough vaccines & therapeutics for challenging diseases for over two decades. Earlier it launched India’s first indigenously developed cell culture H1N1 Swine Flu vaccine. With its promising research over time, India’s hopes are high with COVAXIN.

- Advertisement -

Download the DU Express android application today and stay updated with all the admission updates and college news 24×7 on your smartphone. Click here to download the app | IOS app launching soon.

DU Express is on Telegram (@DUExpressIndia). Subscribe to our channel by clicking here to stay updated with all the latest campus news, admission updates & college events happening near you for free!

- Advertisement -

- Advertisement -

Latest article

‘You’re escalating my anxiety’ – says a DU Student in an Instagram Video on OBE

Had everything gone well, Ima M R would have already completed her B.Sc degree from the University of Delhi. As she was set to...

Liverpool : The Premier League Winners and the Klopp Effect

For those who question the time take by football managers to yield successful results, Liverpool's triumph journey is evident enough that when...

For the ‘First Time in History’, Indian Railways Achieves 100% Punctuality

On 2nd July 2020, The Indian Railways announced that it achieved 100% punctuality of trains. It is the first time that this milestone has...